Genetic variants of folate metabolism and the risk of multiple sclerosis

dc.contributor.authorAsci, Ali Erkan
dc.contributor.authorOrhan, Gurdal
dc.contributor.authorKarahalil, Bensu
dc.date.accessioned2026-02-06T18:45:44Z
dc.date.issued2024
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractBackground and aimsMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) of unknown cause. Alterations in one-carbon metabolism have impact in the pathophysiology by genetic susceptibility to MS and increased the risk of MS. The aim of this study was to investigate the contribution of the gene polymorphism on Methylenetetrahydrofolate Reductase (MTHFR), Methionine Synthase Reductase (MTRR), Methionine Synthase (MTR) enzymes and of the essential factors (homocysteine, Hcy; cysteine, Cys; and vitamin B12, VitB12) in folate metabolism.MethodsEligible MS patients (n = 147) and health controls (n = 127) were participated. The gene polymorphisms were analyzed by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) and the levels of plasma Hcy, Cys and VitB12 were measured by Enzyme Linked Immunuabsorbent Assay (ELISA).Results and conclusionOur results showed that the levels of Hcy and VitB12 were lower and the levels of Cys were higher in MS compared to controls. The observation of high Cys values in all 3 gene polymorphisms suggests that the transsulfiration pathway of Hcy is directed towards Cys formation since the methionine synthesis pathway does not work. We could not find any association with all gene polymorphisms with the risk of MS. The T allele of MTHFR C677T and G allele of MTR A2756G are risk factors for serum Cys level on MS. As for MTR A2756G, serum vitB12 was observed in MS patients with G allele.
dc.identifier.doi10.1080/01616412.2024.2337519
dc.identifier.endpage552
dc.identifier.issn0161-6412
dc.identifier.issn1743-1328
dc.identifier.issue6
dc.identifier.pmid38565201
dc.identifier.scopus2-s2.0-85190262072
dc.identifier.scopusqualityQ3
dc.identifier.startpage544
dc.identifier.urihttps://doi.org/10.1080/01616412.2024.2337519
dc.identifier.urihttps://hdl.handle.net/11129/13936
dc.identifier.volume46
dc.identifier.wosWOS:001195701300001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofNeurological Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectFolate metabolism
dc.subjecthomocystein
dc.subjectcysteine
dc.subjectVitB12
dc.subjectMTHFR
dc.subjectMTRR
dc.subjectMTR
dc.subjectgene polymorphism
dc.titleGenetic variants of folate metabolism and the risk of multiple sclerosis
dc.typeArticle

Files